AU2003274059A8 - Combination of a trioxopyrimidine compound inhibitor and an anti-tumor agent, and uses thereof - Google Patents

Combination of a trioxopyrimidine compound inhibitor and an anti-tumor agent, and uses thereof

Info

Publication number
AU2003274059A8
AU2003274059A8 AU2003274059A AU2003274059A AU2003274059A8 AU 2003274059 A8 AU2003274059 A8 AU 2003274059A8 AU 2003274059 A AU2003274059 A AU 2003274059A AU 2003274059 A AU2003274059 A AU 2003274059A AU 2003274059 A8 AU2003274059 A8 AU 2003274059A8
Authority
AU
Australia
Prior art keywords
combination
tumor agent
compound inhibitor
trioxopyrimidine compound
trioxopyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2003274059A
Other versions
AU2003274059A1 (en
Inventor
Matthias Arlt
Achim Krueger
Sabine Bauer
Hans-Willi Krell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU2003274059A8 publication Critical patent/AU2003274059A8/en
Publication of AU2003274059A1 publication Critical patent/AU2003274059A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003274059A 2002-10-23 2003-10-22 Combination of a trioxopyrimidine compound inhibitor and an anti-tumor agent, and uses thereof Abandoned AU2003274059A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02023710 2002-10-23
EP02023710.3 2002-10-23
PCT/EP2003/011682 WO2004037286A2 (en) 2002-10-23 2003-10-22 Combination of a trioxopyrimidine compound inhibitor and an anti-tumor agent, and uses thereof

Publications (2)

Publication Number Publication Date
AU2003274059A8 true AU2003274059A8 (en) 2004-05-13
AU2003274059A1 AU2003274059A1 (en) 2004-05-13

Family

ID=32116222

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003274059A Abandoned AU2003274059A1 (en) 2002-10-23 2003-10-22 Combination of a trioxopyrimidine compound inhibitor and an anti-tumor agent, and uses thereof

Country Status (2)

Country Link
AU (1) AU2003274059A1 (en)
WO (1) WO2004037286A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2707637A1 (en) 2007-12-17 2009-06-25 Dyax Corp. Compositions and methods for treating osteolytic disorders comprising mmp-14 binding proteins
US8008445B2 (en) 2008-03-03 2011-08-30 Dyax Corp. Metalloproteinase 9 binding proteins
CA2717803A1 (en) * 2008-03-03 2009-09-11 Dyax Corp. Metalloproteinase 9 and metalloproteinase 2 binding proteins
US10314909B2 (en) 2011-10-21 2019-06-11 Dyax Corp. Combination therapy comprising an MMP-14 binding protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2852192B2 (en) * 1994-07-08 1999-01-27 カンセアフォースクニングスフォンデン・アフ・１９８９（フォンデン・チル・フレメ・アフ・エクスペリメンテル・カンセアフォースクニング） uPAR binding site of domain 2 + 3 of uPAR and antibody
WO1997041844A1 (en) * 1996-05-09 1997-11-13 Alcon Laboratories, Inc. Combinations of angiostatic compounds

Also Published As

Publication number Publication date
AU2003274059A1 (en) 2004-05-13
WO2004037286A2 (en) 2004-05-06
WO2004037286A3 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
EG25482A (en) Inhibitors
AU2003202263A1 (en) Roh-kinase inhibitors
HK1077762A1 (en) INHIBITORS OF TFGβ
EP1532133A4 (en) Nf-:b inhibitors
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
GB0202254D0 (en) Prevention of scarring
AU2003277721A8 (en) Beta-nitrostyrene compound and telomerase inhibitor having an anticancer activity
GB2391023B (en) An intumescent assembly
PL397821A1 (en) 1-acetyl-6-fluoro-2-indolinone compound
GB0220385D0 (en) Compound and process
GB0204241D0 (en) Compound
EP1541580A4 (en) Sulfotransferase inhibitors
AU2003244080A1 (en) Phosphodiesterase inhibitor
AU2003274059A8 (en) Combination of a trioxopyrimidine compound inhibitor and an anti-tumor agent, and uses thereof
AU2003218049A8 (en) Targeted immunotherapy of acute lymphoblastic leukemia (all)
GB0224830D0 (en) Compound
AU2003207181A1 (en) Microorganism-trapping agent
GB0213027D0 (en) Compound
GB0211751D0 (en) Compound and process
AU2003249895A1 (en) Combination comprising a vasculostatic compound and an alkylating agent for the treatmemt of a tumor
EP1542674A4 (en) Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof
GB0207491D0 (en) Inhibitors
GB0208094D0 (en) Inhibitors
GB0206031D0 (en) Inhibitors
GB0224102D0 (en) Inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase